
Canyon Eye Associates is proud to be the first practice in the Columbus, Ohio area to offer the Valeda® Light Delivery System—the first FDA-authorized light-based treatment for dry age-related macular degeneration (AMD).
This exciting advancement marks a new chapter in the treatment of dry age-related macular degeneration (AMD), offering eligible patients a safe, non-invasive treatment designed to support retinal health and help preserve vision.
For years, treatment options for dry AMD were limited to routine monitoring, nutritional supplements, and lifestyle recommendations. While those measures remain important, patients now have access to an innovative therapy that works at the cellular level to support healthier retinal function.
As the first practice in the Columbus area to offer this groundbreaking technology, Canyon Eye Associates is proud to provide our patients with access to one of the most significant advances in retinal care in recent years.
Learning that you have dry age-related macular degeneration can be overwhelming. It's natural to have questions about what your diagnosis means and whether there is anything you can do to help protect your vision.
You may be asking yourself:
While there is currently no cure for dry AMD, there is now an FDA-authorized treatment designed to help support retinal health and improve cellular function before significant vision loss occurs.
Valeda® Light Therapy uses photobiomodulation (PBM)—specific wavelengths of red and near-infrared light—to stimulate retinal cells, improve cellular energy production, reduce inflammation, and support healthier retinal function.
Rather than simply watching and waiting, eligible patients now have an opportunity to take a proactive approach to managing dry AMD.
Valeda is an innovative, non-invasive light therapy that delivers carefully controlled wavelengths of red and near-infrared light to the retina.
These wavelengths stimulate the mitochondria—the "powerhouses" inside retinal cells—to improve cellular energy production and support healthier retinal function.
The goal is to help retinal cells perform more efficiently, reduce inflammation, and slow the progression of dry AMD before significant vision loss occurs.
Unlike injections or surgery, Valeda treatment is:
Most treatment sessions take only a few minutes.
✔ First FDA-authorized light therapy for dry AMD
✔ Non-invasive treatment
✔ No injections
✔ No surgery
✔ No medications
✔ No downtime
✔ Comfortable treatment in less than 5 minutes per eye
✔ Designed to help preserve vision and support healthier retinal cells
✔ Available at Canyon Eye Associates—the first practice in the Columbus area to offer Valeda®
Valeda is designed to help eligible patients:
Because every patient is different, individual results may vary. Your physician will determine whether Valeda is an appropriate treatment option for you.
Valeda may be an excellent treatment option if you:
✔ Have been diagnosed with dry age-related macular degeneration
✔ Have early to intermediate dry AMD or otherwise meet the FDA-authorized treatment criteria as determined by your physician
✔ Want a non-invasive treatment option
✔ Want to help preserve your vision
✔ Prefer a treatment without injections or surgery
✔ Are committed to completing the recommended treatment schedule
Valeda may not be appropriate if you:
The best way to determine whether Valeda is right for you is through a comprehensive retinal evaluation by one of our physicians.
As we age, retinal cells naturally become less efficient. Waste material called drusen can accumulate beneath the retina, contributing to dry macular degeneration and gradual vision loss.
Valeda's photobiomodulation therapy helps retinal cells by:
By improving the health of retinal cells, Valeda helps support vision and may slow disease progression.
Treatment is simple, comfortable, and completely non-invasive.
During your appointment:
Some patients notice a temporary light spot or "afterimage" after treatment. This is normal and usually disappears within a few minutes.
There are:
Clinical studies have demonstrated the greatest benefit using the following schedule:
One treatment course every four months for two years
Each course includes:
Consistency is important to maximize the potential benefits of treatment.
At this time, most insurance companies have not established reimbursement policies for Valeda treatment. There are currently no National Coverage Determinations (NCDs) or Local Coverage Determinations (LCDs) for this service.
Because Valeda is currently a self-pay treatment, payment is collected when treatment is scheduled.
To help make this innovative technology more accessible, Canyon Eye Associates offers several payment options.

Includes three complete treatment courses (27 treatments).
Includes the full recommended treatment schedule
Six treatment courses (54 treatments).
Treatment recommendations vary by patient. Some patients require treatment in one eye, while others may benefit from treatment in both eyes. Your physician will discuss the treatment plan that is right for you.
Please reach us at info@canyoneyemd.com if you cannot find an answer to your question.
No. Valeda treatment is completely painless. There are no injections, surgery, or medications involved.
Yes. Valeda has demonstrated an excellent safety profile and is FDA-authorized for eligible patients with dry AMD.
Each treatment course includes 9 sessions over approximately three weeks.
Clinical studies recommend repeating one treatment course every four months for two years.
Yes. There is no recovery period, and most patients resume normal activities immediately after treatment.
Currently, most insurance plans do not provide coverage for Valeda treatment. Our staff will be happy to review pricing and payment options with you.
No. There is currently no cure for dry age-related macular degeneration.
Valeda is designed to support healthier retinal cells, help preserve vision, improve visual function in appropriate patients, and slow disease pro
Some patients notice a temporary light spot or "afterimage" immediately following treatment. This is normal, harmless, and usually disappears within a few minutes.
At Canyon Eye Associates, we are committed to bringing the latest advances in eye care to our patients.
As the first practice in the Columbus, Ohio area to offer the Valeda® Light Delivery System, we are proud to provide innovative, evidence-based treatment for patients living with dry age-related macular degeneration.
Our experienced physicians and clinical team are dedicated to helping patients preserve their vision through advanced technology, personalized care, and compassionate service.
If you have been diagnosed with dry AMD and would like to learn whether Valeda is right for you, we invite you to schedule a consultation.
If you have dry age-related macular degeneration and would like to learn more about Valeda® Light Therapy, contact Canyon Eye Associates today.
Our physicians will determine whether you are a candidate for treatment and develop a personalized treatment plan designed to help protect your vision for years to come.
Call our office today or request an appointment online to learn more.
Valeda® Light Delivery System is FDA-authorized for eligible patients with dry age-related macular degeneration. Individual results may vary. Your physician will determine whether Valeda is appropriate based on your diagnosis, retinal findings, and overall ocular health.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.